Skip to main content
OpenTrials

Clinical trial condition

Sarcoma

Explore clinical trials studying Sarcoma. Study availability and eligibility vary by location and protocol.

629 public trials 171 recruiting studies
Refine in advanced search Browse all conditions

Sarcoma trial results

Active, Not Recruiting

Nivolumab and Ipilimumab in Treating Patients With Rare Tumors

NCT02834013

Conditions
Acinar Cell Carcinoma, Adenocarcinoma, Adenocarcinoma of Lung, +207 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States
  • Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
  • Anchorage Radiation Therapy Center Anchorage, Alaska, United States
View all 1007 locations
View Trial Details
Active, Not Recruiting

Humanized Monoclonal Antibody 3F8 (Hu3F8) With Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF) in the Treatment of Recurrent Osteosarcoma

NCT02502786

Conditions
Neoplasms, Neoplasms by Histologic Type, Neoplasms, Bone Tissue, +5 more
Locations
  • Children's Hospital of Los Angeles (Data Collection Only) Los Angeles, California, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
  • MD ANDERSON CANCER CENTER (Data Collection Only) Houston, Texas, United States
View Trial Details
Active, Not Recruiting

Cabozantinib S-malate and Nivolumab in Treating Patients With Advanced, Recurrent, or Metastatic Endometrial Cancer

NCT03367741

Conditions
Advanced Endometrial Carcinoma, Carcinosarcoma, Endometrial Neoplasms, +19 more
Locations
  • Mayo Clinic Hospital in Arizona Phoenix, Arizona, United States
  • Mayo Clinic in Arizona Scottsdale, Arizona, United States
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • UC San Diego Moores Cancer Center La Jolla, California, United States
View all 34 locations
View Trial Details
Active, Not Recruiting

Testing the Combination of the Anti-cancer Drugs XL184 (Cabozantinib) and Nivolumab in Patients With Advanced Cancer and HIV

NCT04514484

Conditions
Adenocarcinoma, Adnexal Diseases, Advanced Differentiated Thyroid Gland Carcinoma, +141 more
Locations
  • Northwestern University Chicago, Illinois, United States
  • Montefiore Medical Center-Einstein Campus The Bronx, New York, United States
  • University of Pittsburgh Cancer Institute (UPCI) Pittsburgh, Pennsylvania, United States
View Trial Details
Active, Not Recruiting

Mifamurtide Combined With Post-operative Chemotherapy for Newly Diagnosed High Risk Osteosarcoma Patients

NCT03643133

Conditions
Neoplasms, Neoplasms by Histologic Type, Neoplasms, Bone Tissue, +4 more
Locations
  • CHU Amiens-Picardie - Service d'oncologie hématologie pédiatrique Amiens, France
  • CHU d'Angers - Service d'oncologie pédiatrique Angers, France
  • Institut Bergonié - Service d'oncologie médicale Bordeaux, France
  • CHU de Caen - Service d'oncologie hématologie pédiatrique Caen, France
View all 31 locations
View Trial Details

Related conditions